Funder
Sanofi
GlaxoSmithKline
Novartis Pharma
AstraZeneca
Teva Pharmaceutical Industries
Reference32 articles.
1. Severe and difficult-to-treat asthma in adults;Israel;N Engl J Med,2017
2. Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature;Volmer;Eur Respir J,2018
3. Mepolizumab treatment in patients with severe eosinophilic asthma;Ortega;N Engl J Med,2014
4. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials;Castro;Lancet Respir Med,2015
5. Efficacy of intravenous reslizumab in oral corticosteroid–dependent asthma;Nair;J Allergy Clin Immunol Pract,2020
Cited by
127 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献